Sartorius Stedim Biotech S.A.
OTC: SRTOY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Rene Faber
- Employees
- 9,961
- Headquarters
- Aubagne, France
- IPO year
- 2022
- Market cap
- $198.9B
- Website
- https://www.sartorius.com
Loading SRTOY…
Loading profile data…Frequently asked questions about SRTOY
What does Sartorius Stedim Biotech S.A. (SRTOY) do?
Sartorius Stedim Biotech S.A. operates globally, providing essential instruments and consumables to the biopharmaceutical industry. Their product range is extensive, featuring items such as cell lines, cell culture growth media, and bioreactors. The company also supplies solutions for critical processes like the separation, purification, and con...
Where does SRTOY trade?
Sartorius Stedim Biotech S.A. (SRTOY) trades on the Other OTC.
What sector is SRTOY in?
Sartorius Stedim Biotech S.A. (SRTOY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Sartorius Stedim Biotech S.A.?
Rene Faber is the chief executive officer of Sartorius Stedim Biotech S.A. (SRTOY).
Where is Sartorius Stedim Biotech S.A. headquartered?
Sartorius Stedim Biotech S.A. is headquartered in France.
Does SRTOY pay a dividend?
Yes — Sartorius Stedim Biotech S.A. (SRTOY) paid a trailing twelve-month dividend of USD 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SRTOY go public?
Sartorius Stedim Biotech S.A. (SRTOY) completed its initial public offering in 2022.
Is SRTOY an ADR?
Yes — SRTOY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Sartorius Stedim Biotech S.A. reporting and dividends follow the underlying issuer.